Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Confirm Biosciences is a commercial-stage diagnostics and health-wellness company focused on CLIA-waived and FDA-cleared rapid testing products rather than therapeutics. The company supplies point-of-care and at-home diagnostic solutions across drugs-of-abuse testing, infectious disease testing, and women’s health, and also offers private-label development, regulatory support, warehousing, and fulfillment services. Its product portfolio includes urine and oral-fluid drug tests, COVID-19/flu combination tests, pregnancy tests, ovulation tests, UTI strips, and vaginal pH tests. Confirm Biosciences markets through major U.S. retail, employer, clinical, and government channels, and has highlighted broad placement in national chains. The business appears to operate as an acquired but still active subsidiary of Clinical Reference Laboratory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Confirm Biosciences.